pfizer
Pfizer Inc. is one of the world’s largest pharmaceutical companies, headquartered in New York City, USA. It focuses on the discovery, development, manufacturing, and marketing of healthcare products across several areas, including vaccines, oncology, cardiology, immunology, endocrinology, and rare diseases. The company operates globally, with research and commercial facilities in many countries.
Read More
Close
TORONTO-DOMINION BANK, $86.37, Toronto symbol TD, remains a buy for patient, income-seeking investors.
The bank last increased your dividend by 2.9% with the January 2025 payment, to $1.05 a share from $1.02. The new annual rate of $4.20 yields a solid 4.9%.
TD recently settled charges over lapses in the anti-money laundering processes at its U.S....
The bank last increased your dividend by 2.9% with the January 2025 payment, to $1.05 a share from $1.02. The new annual rate of $4.20 yields a solid 4.9%.
TD recently settled charges over lapses in the anti-money laundering processes at its U.S....
ALPHABET INC., Nasdaq symbols GOOG $166.25 [class C: non-voting] and GOOGL $163.99 [class A: one vote per share], remains a buy for aggressive investors.
The company is the parent of Google, the world’s leading Internet search engine—it handles over 80% of global search requests....
The company is the parent of Google, the world’s leading Internet search engine—it handles over 80% of global search requests....
NVIDIA CORP., $124.91, Nasdaq symbol NVDA, is your #1 Aggressive Buy for 2025.
The company is a leading designer of 3D-capable video chips; they make video games run more smoothly and appear more lifelike. Nvidia has also adapted its chips for other applications, including artificial intelligence (AI), datacentres and self-driving cars.
In its fiscal 2025 fourth quarter, ended January 26, 2025, Nvidia’s revenue soared 77.9%, to $39.33 billion from $22.10 billion a year earlier....
The company is a leading designer of 3D-capable video chips; they make video games run more smoothly and appear more lifelike. Nvidia has also adapted its chips for other applications, including artificial intelligence (AI), datacentres and self-driving cars.
In its fiscal 2025 fourth quarter, ended January 26, 2025, Nvidia’s revenue soared 77.9%, to $39.33 billion from $22.10 billion a year earlier....
Pfizer’s earnings soared in 2021 and 2022 thanks to strong demand for its COVID-19 vaccines and treatments. The company used that windfall to buy other drugmakers with promising long-term products, mainly cancer treatments. The company is also aggressively cutting its costs.
Those factors should drive Pfizer’s earnings growth for years to come and let it keep raising your dividend.
PFIZER INC....
Those factors should drive Pfizer’s earnings growth for years to come and let it keep raising your dividend.
PFIZER INC....
J.P. MORGAN CHASE & CO., $264.84, New York symbol JPM, is a buy.
Morgan is the largest banking firm in the U.S., with total assets of $4.00 trillion as of December 31, 2024.
With the October 2024, payment, Morgan increased your quarterly dividend by 8.7%, to $1.25 a share from $1.15....
Morgan is the largest banking firm in the U.S., with total assets of $4.00 trillion as of December 31, 2024.
With the October 2024, payment, Morgan increased your quarterly dividend by 8.7%, to $1.25 a share from $1.15....
J.P. MORGAN CHASE & CO., $259.41, New York symbol JPM, is a buy.
Morgan is the largest banking firm in the U.S., with total assets of $4.00 trillion as of December 31, 2024.
In the three months ended December 31, 2024, Morgan’s earnings soared 54.1%, to $13.67 billion from $8.87 billion a year earlier....
Morgan is the largest banking firm in the U.S., with total assets of $4.00 trillion as of December 31, 2024.
In the three months ended December 31, 2024, Morgan’s earnings soared 54.1%, to $13.67 billion from $8.87 billion a year earlier....
PFIZER INC., $26.59, New York symbol PFE, is a buy.
The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Enbrel (arthritis), Ibrance (breast cancer) and Prevnar (pneumonia).
With the March 2025 payment, Pfizer will raise your quarterly dividend by 2.4%....
The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Enbrel (arthritis), Ibrance (breast cancer) and Prevnar (pneumonia).
With the March 2025 payment, Pfizer will raise your quarterly dividend by 2.4%....
PFIZER INC., $26.37, New York symbol PFE, is your #1 Income Buy for 2024.
The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Enbrel (arthritis), Ibrance (breast cancer) and Prevnar (pneumonia).
With the March 2025 payment, Pfizer will raise your quarterly dividend by 2.4%....
The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Enbrel (arthritis), Ibrance (breast cancer) and Prevnar (pneumonia).
With the March 2025 payment, Pfizer will raise your quarterly dividend by 2.4%....
VIATRIS INC. $12 is a hold. The company (New York symbol VTRS; Income Portfolio, Manufacturing sector; Shares outstanding: 1.2 billion; Market cap: $14.4 billion; Price-to-sales ratio: 1.0; Dividend yield: 4.0%; TSINetwork Rating: Average; www.viatris.com) was formed in November 2020 by the merger of Pfizer’s Upjohn division (generic drugs) with Netherlands-based Mylan N.V....
ABBVIE INC., $199.50, New York symbol ABBV, is a buy.
The company makes biopharmaceuticals, with leading positions in immunology, oncology, aesthetics, neuroscience and eye care.
AbbVie took its current form on January 3, 2013, when Abbott Laboratories (New York symbol ABT) split into two publicly traded firms.
The company will raise your quarterly dividend with the February 2025 payment by 5.8%, to $1.64 a share from $1.55....
The company makes biopharmaceuticals, with leading positions in immunology, oncology, aesthetics, neuroscience and eye care.
AbbVie took its current form on January 3, 2013, when Abbott Laboratories (New York symbol ABT) split into two publicly traded firms.
The company will raise your quarterly dividend with the February 2025 payment by 5.8%, to $1.64 a share from $1.55....